1. Borderline Resectable Pancreatic Cancer: Definitions and the Importance of Multimodality Therapy

   • Douglas B. Evans
   • Beth A. Erickson
   • Paul Ritch

   Pancreatic Tumors 25 August 2010 Pages: 2803 - 2805

2. Disparities in Utilization of High-Volume Hospitals for Cancer Surgery: Results of a Korean Population-Based Study

   • So Young Kim
   • Jong Hyock Park
   • Eun Cheol Park

   Healthcare Policy and Outcomes 10 June 2010 Pages: 2806 - 2815

   

3. Rehospitalization among Elderly Patients with Thyroid Cancer after Thyroidectomy are Prevalent and Costly

   • Charles T. Tuggle
   • Lesley S. Park
   • Julie Ann Sosa

   Healthcare Policy and Outcomes 15 June 2010 Pages: 2816 - 2823

   

4. Trends in Centralization of Cancer Surgery

   • Karyn B. Stitzenberg
   • Neal J. Meropol

   Healthcare Policy and Outcomes 18 June 2010 Pages: 2824 - 2831

   

5. Defining Venous Involvement in Borderline Resectable Pancreatic Cancer

   • Yun Shin Chun
   • Barton N. Milestone
   • John P. Hoffman

   Pancreatic Tumors 20 August 2010 Pages: 2832 - 2838

   

6. Absence of hMLH1 or hMSH2 Expression as a Stage-Dependent Prognostic Factor in Sporadic Colorectal Cancers

   • Ji Won Park
   • Hee Jin Chang
   • Seung-Yong Jeong

   Colorectal Cancer 12 June 2010 Pages: 2839 - 2846

   

7. Prognostic Value of the Lymph Node Ratio in Stage III Colorectal Cancer: A Systematic Review

   • W. Ceelen
   • Y. Van Nieuwenhove
   • P. Pattyn

   Colorectal Cancer 18 June 2010 Pages: 2847 - 2855

   

8. Robotic Right Colon Resection: Evaluation of First 50 Consecutive Cases for Malignant Disease

   • Annibale D’Annibale
   • Graziano Pernazza
   • Gianna Sovernigo

   Colorectal Cancer 22 June 2010 Pages: 2856 - 2862

   

9. Long-Term Survival and Recurrence Outcomes Following Surgery for Distal Rectal Cancer

   • Eric J. Silberfein
   • Kiran M. Kattepogu
   • George J. Chang

   Colorectal Cancer 15 June 2010 Pages: 2863 - 2869

   

10. Extended Preoperative Chemotherapy Does Not Improve Pathologic Response and Increases Postoperative Liver Insufficiency After Hepatic Resection for Colorectal Liver Metastases

    • Yoji Kishi
    • Daria Zorzi
    • Jean-Nicolas Vauthey

    Hepatobiliary Tumors 22 June 2010 Pages: 2870 - 2876

    

11. Radiosurgery of Liver Tumors: Value of Robotic Radiosurgical Device to Treat Liver Tumors

    • Sebastian Stintzing
    • Ralf-Thorsten Hoffmann
    • Alexander Muacevic

    Radiation Oncology 24 June 2010 Pages: 2877 - 2883

    

12. Predicting Four or More Metastatic Axillary Lymph Nodes in Patients with Sentinel Node-Positive Breast Cancer: Assessment of Existent Risk Scores

    • Benjamin Zendejas
    • Tanya L. Hoskin
    • Judy C. Boughey

    Breast Oncology 29 April 2010 Pages: 2884 - 2891

    

13. Pathological Processing Techniques and Final Diagnosis of Breast Cancer Sentinel Lymph Nodes

    • Florian Rudolf Fritzsche
    • Tanja Reineke
    • Zsuzsanna Varga

    Breast Oncology 04 May 2010 Pages: 2892 - 2898

    

14. Present-Day Locoregional Control in Patients with T1 or T2 Breast Cancer with 0 and 1 to 3 Positive Lymph Nodes After Mastectomy Without Radiotherapy

    • Ranjna Sharma
    • Isabelle Bedrosian
    • Henry M. Kuerer

    Breast Oncology 05 May 2010 Pages: 2899 - 2908

    

15. Minimal Disease in the Sentinel Lymph Node: How to Best Measure Sentinel Node Micrometastases to Predict Risk of Additional Non-Sentinel Lymph Node Disease

    • Shicha Kumar
    • Matthew Bramlage
    • Kimberly J. Van Zee

    Breast Oncology 09 June 2010 Pages: 2909 - 2919

16. Sentinel Lymph Node Intraoperative Imprint Cytology in Patients with Breast Cancer—Costly or Cost Effective?

    • Jan P. Kamiński
    • Doug Case
    • Edward A. Levine

    Breast Oncology 22 June 2010 Pages: 2920 - 2925

17. Tissue Expander Breast Reconstruction is Not Associated with an Increased Risk of Lymphedema

    • Tomer Avraham
    • Sanjay V. Daluvoy
    • Babak J. Mehrara

    Breast Oncology 25 May 2010 Pages: 2926 - 2932

18. The Effect of Simultaneous Peripheral Excision in Breast Conservation upon Margin Status

    • Roshani R. Patel
    • Tianyu Li
    • Richard J. Bleicher

    Breast Oncology 12 June 2010 Pages: 2933 - 2939

    

19. Ductal Carcinoma in Situ of the Breast Treated with Accelerated Partial Breast Irradiation Using Balloon-Based Brachytherapy

    • Philip Z. Israel
    • Frank Vicini
    • Maureen Lyden

    Breast Oncology 05 May 2010 Pages: 2940 - 2944

20. Immediate Microvascular Breast Reconstruction After Neoadjuvant Chemotherapy: Complication Rates and Effect on Start of Adjuvant Treatment

    • Mirjam Zweifel-Schlatter
    • Nagham Darhouse
    • Jian Farhadi

    Reconstructive Oncology 29 June 2010 Pages: 2945 - 2950

    

21. Role of Systematic Lymphadenectomy and Adjuvant Radiation in Early-Stage Endometrioid Uterine Cancer

    • Nan-Hee Jeong
    • Jong-Min Lee
    • Ki-Tae Kim

    Gynecologic Oncology 17 June 2010 Pages: 2951 - 2957

    

22. 25-Hydroxyvitamin D Status Does Not Affect Intraoperative Parathyroid Hormone Dynamics in Patients with Primary Hyperparathyroidism

    • Joel T. Adler
    • Rebecca S. Sippel
    • Herbert Chen

    Endocrine Tumors 11 June 2010 Pages: 2958 - 2962

    

23. Prospective Evaluation of the Rate and Impact of Hemolysis on Intraoperative Parathyroid Hormone (IOPTH) Assay Results

    • Jacob Moalem
    • Daniel T. Ruan
    • Electron Kebebew

    Endocrine Tumors 15 June 2010 Pages: 2963 - 2969

    

24. Sentinel Lymph Node Biopsy for Papillary Thyroid Cancer: 12 Years of Experience at a Single Institution

    • Deborah K. Cunningham
    • Katherine A. Yao
    • Armando E. Giuliano

    Endocrine Tumors 15 June 2010 Pages: 2970 - 2975

    

25. Association of High Levels of Jagged-1 and Notch-1 Expression with Poor Prognosis in Head and Neck Cancer

    • Jen-Tsun Lin
    • Mu-Kuan Chen
    • Pey-Jium Chang

    Head and Neck Oncology 02 June 2010 Pages: 2976 - 2983

    

26. Tongue and Buccal Mucosa Carcinoma: Is There a Difference in Outcome?

    • Chun-Ta Liao
    • Shiang-Fu Huang
    • Tzu-Chen Yen

    Head and Neck Oncology 22 June 2010 Pages: 2984 - 2991

    

27. The Prognostic Value of Tumor Mitotic Rate and Other Clinicopathologic Factors in Patients with Locoregional Recurrences of Melanoma

    • Rajmohan Murali
    • Marc D. Moncrieff
    • Richard A. Scolyer

    Melanomas 28 April 2010 Pages: 2992 - 2999

    

28. Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases

    • Carlo Riccardo Rossi
    • Sandro Pasquali
    • Donato Nitti

    Melanomas 29 April 2010 Pages: 3000 - 3007

29. Detection of Melanoma Nodal Metastases; Differences in Detection Between Elderly and Younger Patients Do Not Affect Survival

    • S. Kruijff
    • E. Bastiaannet
    • H. J. Hoekstra

    Melanomas Open access 05 May 2010 Pages: 3008 - 3014

    

30. Total Sentinel Lymph Node Tumor Size Predicts Nonsentinel Node Metastasis and Survival in Patients with Melanoma

    • Ali Cadili
    • Richard A. Scolyer
    • John F. Thompson

    Melanomas 15 June 2010 Pages: 3015 - 3020

31. Osteosarcoma of the Proximal Tibia: Limb-Sparing Resection and Reconstruction with a Modular Segmental Proximal Tibia Tumor Prosthesis

    • James C. Wittig
    • Camilo E. Villalobos
    • Martin Malawer

    Bone and Soft Tissue Sarcomas 07 July 2010 Pages: 3021 - 3021

32. New Predictors of Response to Neoadjuvant Chemotherapy and Survival for Invasive Thymoma: a Retrospective Analysis

    • Tommaso Claudio Mineo
    • Davide Mineo
    • Vincenzo Ambrogi

    Thoracic Oncology 22 June 2010 Pages: 3022 - 3029

    

33. Abnormal Expression of PFDN4 in Colorectal Cancer: A Novel Marker for Prognosis

    • Norikatsu Miyoshi
    • Hideshi Ishii
    • Masaki Mori

    Translational Research and Biomarkers 15 June 2010 Pages: 3030 - 3036

    

34. Clinical Significance of Human Kallikrein7 Gene Expression in Colorectal Cancer

    • Yasuhiro Inoue
    • Takehiko Yokobori
    • Masato Kusunoki

    Translational Research and Biomarkers 11 June 2010 Pages: 3037 - 3042

    

35. Osteopontin Expression is an Independent Adverse Prognostic Factor in Resectable Gastrointestinal Stromal Tumor and its Interaction with CD44 Promotes Tumor Proliferation

    • Kai-Hsi Hsu
    • Hung-Wen Tsai
    • Pei-Jung Lu

    Translational Research and Biomarkers 12 June 2010 Pages: 3043 - 3052

    

36. Mucinous Gastric Cancer Presents with More Advanced Tumor Stage and Weaker β-Catenin Expression than Nonmucinous Cancer

    • Min-Gew Choi
    • Chang Ohk Sung
    • Jae Moon Bae

    Gastrointestinal Oncology 20 July 2010 Pages: 3053 - 3058

    

37. Prognostic Significance of E-cadherin Expression and Peripheral Blood Micrometastasis in Gastric Carcinoma Patients

    • Abeer A. Saad
    • Nahla M. Awed
    • Sahar S. Ezz-Elarab

    Translational Research and Biomarkers 19 June 2010 Pages: 3059 - 3067

    

38. Role of MMP-3 and MMP-9 and Their Haplotypes in Risk of Bladder Cancer in North Indian Cohort

    • Priyanka Srivastava
    • Anil Mandhani
    • Rama D. Mittal

    Translational Research and Biomarkers 24 June 2010 Pages: 3068 - 3075